Results 41 to 50 of about 2,876 (217)

Perception of surface stickiness in different sensory modalities: an functional MRI study [PDF]

open access: yes, 2020
Surface texture can be perceived not only from tactile, but also from auditory and visual sensory cues. In our previous psychophysical study, we demonstrated that humans can recognize surface stickiness using only one kind of sensory modality without any
Kim, Junsuk, Kim, Sung-Phil, So, Yosup
core   +1 more source

Effectiveness of unilateral sequential video-assisted sympathetic chain blockage for primary palmar hyperidrosis in children and adolescents

open access: yesFrontiers in Pediatrics, 2022
IntroductionPrimary palmar hyperhidrosis (PPH) is a severely debilitating condition that can affect patients of any age. Thoracoscopic sympathectomy provides a definitive treatment for PPH.
Ottavio Adorisio   +5 more
doaj   +1 more source

Resympathectomy for palmar and axillary hyperhidrosis

open access: yesJournal of British Surgery, 1998
Abstract Background The aim was to analyse patterns of failure or symptom recurrence after primary sympathectomy for palmar or axillary hyperhidrosis, and to carry out tactical problem-solving for resympathectomy and review the operative findings ...
C P, Hsu   +3 more
openaire   +2 more sources

Upregulation of ITGB6 in primary palmar hyperhidrosis

open access: yesAdvances in Clinical and Experimental Medicine, 2023
Supplementary Table 1. Data analysis for Figure 1A-C, 2B & D, 3B, 4A-C, 5A & C. Supplementary Table 2. Data analysis for PCA rotation (Figure 4A).
Lin, Jian-Bo   +3 more
openaire   +2 more sources

Long-term outcomes associated to video-assisted thoracic sympathotomy for palmar-axillar subtype of the hyperhidrosis

open access: yesArquivos de Neuro-Psiquiatria, 2012
OBJECTIVE: Surgery for both palmar and axillar hyperhidrosis usually includes the interruption of the sympathetic chain in multiple levels. This study aimed to determine the long-term outcomes associated to video-assisted thoracic sympathotomy (VATS) of ...
Leandro Pretto Flores
doaj   +1 more source

Thoracic sympathectomy for hyperhidrosis with and without botulinum toxin injection

open access: yesAl-Azhar Assiut Medical Journal, 2019
Background and aims Primary hyperhidrosis is a disorder of excessive sweating of unknown etiology, associated with emotional, psychological, and educational problems.
Rezk Abu-Gamila   +2 more
doaj   +1 more source

Research of primary hyperhidrosis in students of medicine of the State of Sergipe, Brazil [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2015
BACKGROUND:Hyperhidrosis or excessive sweat production occurs at 2.9-9% of the population.OBJECTIVE:To estimate the prevalence and disorders due to primary hyperhidrosis (HP) in medicine students in the state of Sergipe.METHODS:Cross-sectional study ...
Sônia Oliveira Lima   +5 more
doaj   +1 more source

KDM2B‐Related Neurodevelopmental Disorder A Case‐Series Supporting the CxxC Domain Phenotype With Emphasis on Ocular and Dermatologic Features

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 5, Page 1098-1104, May 2026.
ABSTRACT The KDM2B‐related neurodevelopmental disorder is a recently identified Mendelian disorder of the epigenetic machinery associated with pathogenic variants in KDM2B. Global developmental delay, intellectual disability, congenital anomalies, and systemic manifestations characterize the disorder.
Adriana Gomes   +3 more
wiley   +1 more source

Selective T3–T4 sympathicotomy versus gray ramicotomy on outcome and quality of life in hyperhidrosis patients: a randomized clinical trial

open access: yesScientific Reports, 2021
Compensatory hyperhidrosis is the leading cause of patients' dissatisfaction after thoracic sympathicotomy. The study aimed to reduce compensatory hyperhidrosis to increase patients’ satisfaction.
Vicente Vanaclocha   +6 more
doaj   +1 more source

Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review

open access: yesToxins, 2023
Botulinum toxin type B (BoNT-B), known as Myobloc® in the United States and as Neurobloc® in Europe, is a new therapeutically available serotype among the botulinum toxin family.
Anna Campanati   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy